ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
1.69
0.095
(5.96%)
Closed September 18 11:30AM

Immupharma Plc Financial Summary

The current IMM market cap is 7.04M. The company's latest EPS is GBP -0.0070 and P/E is -2.39.

Year End December 30 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Revenue 78k127k118k00
Operating Income -6.81M-5.59M-6.59M-3.03M-3.06M
Net Income -6.12M-6.86M-8.17M-3.81M-2.92M
Year End December 30 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Assets 5.8M10.92M6M3.98M2.72M
Total Liabilities 532k1.26M1.58M1.45M1.67M
Total Equity 5.27M9.66M4.41M2.52M1.06M

Cash Flow

Year End December 30 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Operating -4.22M-3.33M-4.83M-2.35M-1.36M
Investing -101k-569k-50k-77k189k
Financing 326k8.37M702k1.55M722k
Market Cap 7.04M
Price to Earnings Ratio -2.39
Price to Sales Ratio 0
Price to Cash Ratio 33.4
Price to Book Ratio 6.59
Dividend Yield -

Share Statistics

Shares Outstanding 416.44M
Average Volume (1 week) 843.33k
Average Volume (1 Month) 1.96M
52 Week Change -8.65%
52 Week High 2.90
52 Week Low 0.83
Spread (Intraday) 0.08 (4.62%)

Company Info

Company Name Immupharma Plc
Address one bartholomew close
london EC1A 7BL
Website https://www.immupharma.com
Industry finance diversified (F)

Your Recent History

Delayed Upgrade Clock